Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekKFF Health News ↗
This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements w…
The WeekBioPharma Dive ↗
The deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon l…
The WeekPharmaVoice ↗
Merck is the most exposed to risk from generic competition in the short term, but AbbVie, Johnson & Johnso…
The WeekBriefing
Drug Channels points to a sharp 2025 shift in Medicare Part D MS coverage toward generics after years of brand…
The WeekPharmaceutical Technology ↗
In its first global guidelines for child and adolescent obesity, the WHO says diet, exercise, and behavioural …
The WeekSTAT News ↗
Smaller biotech firms are trying to figure out how to win exemptions from Trump's import taxes.…
The WeekAJMC ↗
As Mantle Cell Lymphoma Risk Tools Advance, Access Lags Behind…
The WeekBioPharma Dive ↗
Despite having an allogeneic cell therapy prospect that's ready for late-stage testing in lymphoma, Caribou co…
The WeekPharmaVoice ↗
The program, part of Operation TrialBlazer, aims to speed early research and help the U.S. bring trials back f…
The WeekBriefing
GE HealthCare is buying Sofie Biosciences for $945 million. The deal points to the strategic value of radiopha…
The WeekPharmaceutical Technology ↗
Rocket Pharmaceuticals has entered into a credit facility agreement of up to $150m with Hercules Capital to su…
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we put the finishing touches on DCI's 2026-27 Economic Rep…
The WeekSTAT News ↗
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical …
The WeekAJMC ↗
Will Cancer Care Come Home by 2030? PCOC Panelists Differ on Strategy…
The WeekBioPharma Dive ↗
The fundraise is the firm's largest to date, providing a lift for a European biotech industry that's fallen fu…
The WeekPharmaVoice ↗
Where pharma and biotech leaders will converge to network, share ideas and potentially strike deals.…
The WeekPharmaVoice ↗
Alveus, Lilly, Viking and Amgen are testing maintenance strategies as durability becomes a bigger focus in obe…
The WeekBriefing
KFF’s Oct. 6 poll shows voters remain focused on health care affordability, while Democrats widened their adva…
The WeekPharmaceutical Technology ↗
Lilly is continuing to bet on the molecular gate approach, which Gate says could create therapies targeting ha…
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we put the finishing touches on DCI's 2026-27 Economic Rep…
The WeekSTAT News ↗
Researchers found pulse oximeters went from overestimating blood oxygen levels to underestimating them; inaccu…
The WeekAJMC ↗
Value-Based Oncology After the Enhancing Oncology Model…
The WeekBioPharma Dive ↗
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the co…
The WeekPharmaVoice ↗
Dr. John Tsai grabbed the reins of global R&D this year with a clear mandate: extend Daiichi's oncology mo…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.